Prior authorization persists because it works for the system that created it. This essay explains how cost control, risk management, and delay shape patient outcomes, why reform keeps falling short, and what must change to align financial incentives with timely care.

Only 0.2% of patients appeal insurance denials, yet 80% succeed. This article examines how even small increases in appeals could shift insurer behavior, raise costs, influence Wall Street expectations, and reshape the economics of American healthcare.

Mark Cuban is stepping in where insurers fail, funding care and challenging the system. But real change will not come from policy alone. A unified patient voting bloc could reshape healthcare power in America.

Matthew Zachary joins Humanity Rx to break down how modern cancer care improves survival while leaving patients exposed to medical debt, prior authorization delays, and financial risk, and why policy change depends on organized patient power.

Gallup reports 82 million Americans cut back on daily life to afford healthcare. Coverage shifts financial risk to families through deductibles and prior authorization. Diagnosis now operates like a private tax on survival and forces tradeoffs across work, housing, and retirement.

After 22 years away from solo performance, Matthew Zachary returns to the stage April 28 at Merkin Concert Hall in NYC. A live piano concert marking 30 years since brain cancer, featuring stories from the cancer community and the launch of We the Patients.

Millions cycle through eczema treatments that calm symptoms but never fix the cause. This essay explains how payment models, regulation, and product marketing keep patients trapped in repeat care instead of long term prevention.

Mark Cuban walked into the Senate with spreadsheets and receipts. He called PBMs a cartel. He saved Medicare $2 billion. But math doesn't show up at town halls. Receipts don't vote. Here's the hole in his equation and an invitation to fix it.

Mark Cuban exposes PBM corruption and champions transparent drug pricing. He is right about generics. He is wrong about cash solving catastrophic care. A brain cancer survivor explains why $12 prescriptions and $960,000 transplants live in different universes.

Jenny Opalinski worked ICU floors where 10 to 15 traumatic events can hit in a single shift. In EP432 of Out of Patients she confronts clinician burnout, moral injury, and the cost of empathy in healthcare. A raw conversation about survival inside a system that grinds people down.

Matthew Zachary reads from We the Patients for the first time at the Cervivor Summit. Surrounded by cervical cancer survivors, he breaks down while honoring families crushed by medical debt and systemic failure. A defining moment ahead of the book’s May 2026 release.

Health systems consolidate. Insurers post record profits. Employers spend $20,000 per employee on coverage while workers fight denials alone at 11 pm. Insurance middlemen now cost more than the drugs. The system rewards delay and calls it complexity. Families call it Tuesday.

Mount Sinai and Anthem fight over 450 million dollars while 200000 patients scramble to keep their doctors and cancer treatment. Corporate contract disputes now function as leverage tactics, turning patients into bargaining chips in rate negotiations.

A personal reflection on Gil Bashe’s Healing the Sick Care System and the growing revolt against insurance driven harm. From hospital memories to national accountability, this piece calls out who holds the wheel and why 2026 signals the rise of the patient voter bloc.

The new bipartisan proposal to separate insurers, PBMs, and providers targets the financial structure behind rising costs and denials. This piece explains how ownership concentration reshaped care, why regulation failed, and what structural separation could change for patients.

We The Patients LIVE Raleigh brought patients clinicians policymakers and journalists into the same room to confront how healthcare harm actually forms. What emerged was clarity accountability and the beginning of a different kind of conversation about power trust and consequence.

Insurance companies promise reform while patients absorb delay and denial. From IVIG rejections to cancer imaging hold ups, this essay documents how prior authorization functions in real life and why patients now recognize the pattern.

Blue Cross Blue Shield of North Carolina demanded another review of an already-approved, externally-reviewed IVIG infusion—48 hours before treatment. For a patient with life-threatening hypersensitivity reactions. This is how the denial machine works, and how one patient fought back and won.

A blinking answering machine. That's how I found out I had brain cancer. I was 21. Thirty years later, I wrote a book about it. "We the Patients" isn't a memoir—it's a manual. The system isn't broken. It was built this way. Don't try to fix it. Rig it in your favor. This book shows you how.

I was 21. Brain cancer came via a blinking answering machine. There was barely an internet. No young adult programs. We kind of all just died back then. But I didn't. I've watched three decades of impossible become ordinary—and it's been the greatest terrible privilege. 2026 is the Year of the Patient.